GTLS vs VRTX · rev $4.16B vs P/E 30, rev $3.33B
Chart Industries Inc (GTLS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Chart Industries Inc (GTLS) is a specialty industrial machinery company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported GTLS revenue for 2024-12-31 was $4.16B. Net income was $232.8M. Revenue was up 24.1% from 2023-12-31 to 2024-12-31. GTLS currently screens at market cap $9.90B.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GTLS currently screens at market cap $9.90B. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GTLS and VRTX stock pages for the full models.
Not investment advice.